经导管主动脉瓣植入术与胸主动脉腔内修复术中脑栓塞预防的证据
本系统综述检索456篇文献后纳入18项研究,评估脑保护装置(EPD)和二氧化碳冲洗(CDF)在经导管主动脉瓣植入术(TAVI)与胸主动脉腔内修复术(TEVAR)中的疗效。TAVI中使用EPD可减少影像学脑栓塞病灶体积,但未能证明临床预防栓塞性卒中;TEVAR中使用EPD和CDF被建议,但证据不足以支持常规临床使用。
要点
- TAVI中EPD组影像学脑病灶总体积和单病灶体积均小于无EPD组
- TAVI中EPD在术后神经认知评估表现更好,但未能证明临床预防栓塞性卒中
- TEVAR中EPD和CDF被建议使用,但证据不足以支持常规临床使用
核心结论
- 系统综述表明TAVI中使用EPD安全可行,虽有I级证据显示影像学栓塞病灶减少,但临床结局改善尚未证实。
- TEVAR中使用EPD和CDF被建议,但证据仍不足以支持常规临床使用。
研究设计与样本
- 系统综述,按照PRISMA声明进行文献检索,检索PubMed、OvidSP、MEDLINE、Web of Science核心合集和Cochrane图书馆,纳入会议摘要和论文集,排除超出关注范围和综述类文章。
- 456篇检索文献中18项研究符合纳入标准。
主要发现
- TAVI中EPD与无EPD比较的系统综述显示,所有研究中EPD患者脑病灶总体积更小、单病灶体积更小。
- TAVI中EPD患者在术后神经认知评估表现更好,但所有研究均未能证明临床预防栓塞性卒中。
- TEVAR中EPD使用的2项前瞻性先导研究所有病例均显示捕获栓塞碎片且无早期术后神经认知缺陷。
- TEVAR中CDF的1项体外研究显示支架移植物释放期间释放的气体栓塞显著减少。
- TEVAR中CDF的1项队列研究显示所有患者成功应用CDF,仅1例术后非致残性卒中。
临床怎么用
- 作者认为TAVI中EPD使用安全可行,有I级证据显示影像学栓塞病灶减少,但临床结局改善尚未证实。
- 作者建议TEVAR中使用EPD和CDF,但证据不足以支持常规临床使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Embolic stroke is a formidable complication of transcatheter aortic valve implantation (TAVI) and thoracic endovascular aortic repair (TEVAR). Mechanical strategies to reduce the risk of ischemic embolic lesions include embolic protection devices (EPDs) and carbon dioxide flushing (CDF). This study aims to assess the efficacy for EPD and CDF uses in TAVI and TEVAR. METHODS: A literature review was performed according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis. All searches were performed via PubMed, OvidSP, MEDLINE, Web of Science Core Collection, and Cochrane Library. Conference abstracts and proceedings were included. Those that were out of scope of interest and review articles were excluded. RESULTS: Eighteen studies fulfilled the inclusion criteria of the 456 articles searched. Regarding EPD use in TAVI, systematic review comparing EPD with no-EPD showed smaller total volume of cerebral lesions and smaller volume per lesion in patients with EPD in all studies. They also performed better in postoperative neurocognitive assessments but could not demonstrate clinical prevention of embolic stroke in all studies. While for EPD use in TEVAR, capture of embolic debris and absence of early postoperative neurocognitive deficit were demonstrated in all cases of 2 prospective pilot studies. Concerning CDF in TEVAR, significant reduction in gaseous emboli released during stent-graft deployment was shown by 1 in vitro study. Successful CDF application in all patients, with only 1 case of postoperative nondisabling stroke, was also demonstrated by 1 cohort study. CONCLUSIONS: This systematic review of medical literature has demonstrated the safety and feasibility of EPD use in TAVI. Although improvements in clinical outcomes have yet been demonstrated, there was level I evidence showing reduced embolic lesions in imaging. The use of EPD and CDF in TEVAR was suggested, but evidence remained inadequate to support routine clinical use.
引用
- Lam HT, Kwong JM, Lam PL, et al. Evidence for Cerebral Embolic Prevention in Transcatheter Aortic Valve Implantation and Thoracic Endovascular Aortic Repair. Ann Vasc Surg. 2018. PMID: 30218830. doi:10.1016/j.avsg.2018.06.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。